Aeris Environmental Ltd (ASX: AEI) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Aeris Environmental Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$12.33 million
P/E Ratio
17.30
Dividend Yield
0.00%
Shares Outstanding
246.59 million
Earnings per share
-0.017
Dividend per share
N/A
Year To Date Return
-7.14%
Earnings Yield
5.78%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Aeris Environmental Ltd (ASX: AEI)
Latest News
Share Market News
Aeris (ASX:AEI) share price charges 6% higher on partnership deal
Share Gainers
These ASX shares are fighting the spread of coronavirus
⏸️ Investing
10 stocks up by more than 50% in the past month
AEI ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Aeris Environmental Ltd
Aeris Environmental Ltd is engaged in the research, development, and commercialisation of proprietary technologies and the distribution of HVAC/R Hygiene, anti-corrosion, and disinfectant products. It also provides services related to HVAC/R, Hygiene and Remediation Technology, Indoor Air Quality, and Corrosion Protection services. The group provides solutions for Home Cleaning, Aged Care Cleaning, School & Office Cleaning, and Flood Remediation. Its geographic reportable segments are Australia and International. The company generates a majority of its revenue from Australia.
AEI Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 13 Feb 2026 | $0.05 | $0.00 | 0.00% | 504,876 | $0.05 | $0.05 | $0.05 |
| 12 Feb 2026 | $0.05 | $0.00 | 0.00% | 185,824 | $0.05 | $0.05 | $0.05 |
| 11 Feb 2026 | $0.05 | $0.00 | 0.00% | 693,364 | $0.05 | $0.05 | $0.05 |
| 09 Feb 2026 | $0.05 | $0.00 | 0.00% | 364,512 | $0.05 | $0.05 | $0.05 |
| 06 Feb 2026 | $0.05 | $0.00 | 0.00% | 327,557 | $0.05 | $0.05 | $0.05 |
| 05 Feb 2026 | $0.05 | $0.00 | 0.00% | 44,728 | $0.05 | $0.05 | $0.05 |
| 04 Feb 2026 | $0.05 | $0.00 | 0.00% | 5,000 | $0.05 | $0.05 | $0.05 |
| 03 Feb 2026 | $0.05 | $0.00 | 0.00% | 10,000 | $0.05 | $0.05 | $0.05 |
| 02 Feb 2026 | $0.05 | $0.00 | 0.00% | 45,000 | $0.05 | $0.05 | $0.05 |
| 29 Jan 2026 | $0.05 | $0.00 | 0.00% | 5,000 | $0.05 | $0.05 | $0.05 |
| 28 Jan 2026 | $0.05 | $0.00 | 0.00% | 1 | $0.05 | $0.05 | $0.05 |
| 27 Jan 2026 | $0.05 | $0.00 | 0.00% | 321,527 | $0.05 | $0.05 | $0.05 |
| 23 Jan 2026 | $0.05 | $0.00 | 0.00% | 139,913 | $0.05 | $0.05 | $0.05 |
| 20 Jan 2026 | $0.06 | $0.00 | 0.00% | 150,000 | $0.06 | $0.06 | $0.06 |
| 19 Jan 2026 | $0.06 | $0.00 | 0.00% | 270,269 | $0.06 | $0.06 | $0.06 |
| 16 Jan 2026 | $0.06 | $0.00 | 0.00% | 32,637 | $0.06 | $0.06 | $0.06 |
| 15 Jan 2026 | $0.06 | $0.00 | 0.00% | 143 | $0.06 | $0.06 | $0.06 |
| 14 Jan 2026 | $0.06 | $0.00 | 0.00% | 16,524 | $0.06 | $0.06 | $0.06 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 23 Jun 2025 | Maurie Stang | Buy | 8,166,667 | $302,166 |
On-market trade.
|
| 23 Jun 2025 | Steven Kritzler | Buy | 8,166,667 | $302,166 |
On-market trade.
|
| 10 Jun 2025 | Steven Kritzler | Buy | 2,500,000 | $75,000 |
Off-market trade.
|
| 10 Apr 2025 | Maurie Stang | Transfer | 5,529,411 | $293,058 |
As advised by the company. 5,529,411 shares
were transferred to Energy Trading Systems Pty Ltd <MPF A/C> from Maurie Stang |
| 10 Apr 2025 | Maurie Stang | Buy | 50,000 | $8,587 |
Off-market trade.
|
| 10 Apr 2025 | Maurie Stang | Transfer | 5,529,411 | $293,058 |
As advised by the company. 5,529,411 shares
were transferred to Energy Trading Systems Pty Ltd <MPF A/C> from Maurie Stang |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Maurie Stang | Non-Executive ChairmanNon-Executive Director | Jul 2002 |
Mr Stang has more than four decades of experience building and managing companies in the healthcare and biotechnology industry in Australia and internationally. His business development and marketing skills have resulted in the commercialisation of intellectual property across global markets. Mr Stang has been the Executive Chairman of unlisted company Lumitron Technologies Inc. since 2016. He is member of Risk Committee and Corporate Governance Committee.
|
| Mr Steven Kritzler | Non-Executive Director | Feb 2005 |
Mr Kritzler holds a number of international patents. He is the Technical Director of Novapharm Research (Australia) Pty Ltd. Mr Kritzler has over 40 years of experience in commercial R&D in the areas of pharmaceutical, medical, cosmetic and speciality industrial products.
|
| Dr Jenny Lee Harry | Non-Executive Director | Apr 2021 |
Dr Harry co-founded Proteome Systems Limited with the team who pioneered the scientific field of proteomics, and commercialised a suite of disruptive technologies in Australia, the USA and Japan. Dr Harry has 25 years' experience in executive management of companies in the biotechnology, diagnostic and biopharmaceutical sectors, and is a CEO in early-stage companies to commercialise products. She is an experienced Independent Director on the Boards of listed and unlisted companies, and is currently a Non-Executive Director of unlisted company Lumitron Technologies Inc. Dr Harry is chair of Risk Committee and Corporate Governance Committee.
|
| Dr Abbie Widin | Non-Executive Director | Mar 2021 |
Dr Widin has more than 20 years' executive and board experience across consumer goods, consulting, robotics and AI. She has held senior international roles with Procter & Gamble in Europe and Australia, and with Kellogg in Asia Pacific. Dr Widin is also the founder and CEO of a robotics and AI proptech business, with a focus on commercialisation and data stewardship in regulated sectors. She is currently a Non-Executive Director of the Agricultural Business Research Institute (ABRI). Dr Widin brings experience in governance, commercialisation of new technologies and IP, capital raising, and go-to-market strategy.
|
| Mr Andrew Ian Just | Chief Executive Officer | Mar 2022 |
-
|
| Mr Robert John Waring | Company Secretary | Jul 2002 |
-
|
| Andrew Ian Just | Chief Executive Officer |
-
|
|
| Robert John Waring | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Bernard Stang | 19,293,084 | 7.83% |
| Epitek Corporation Pty Limited | 16,586,568 | 6.73% |
| Maurie Stang | 15,279,749 | 6.20% |
| Steven Kritzler <S Kritzler Family A/C> | 10,831,609 | 4.39% |
| HSBC Custody Nominees (Australia) Limited | 9,017,719 | 3.66% |
| Steven Kenneth Kritzler | 8,166,667 | 3.31% |
| Kefford Holdings Pty Ltd <The Kefford Family A/C> | 6,813,610 | 2.76% |
| Towns Corporation Pty Ltd <PAE Family A/C> | 6,730,532 | 2.73% |
| Potski Pty Ltd <Potski Super Fund A/C> | 6,617,604 | 2.68% |
| Netwealth Investments Limited <Wrap Services A/C> | 6,602,461 | 2.68% |
| Energy Trading Systems Pty Ltd <MPF A/C> | 5,529,411 | 2.24% |
| Meditsuper Pty Ltd <Medi Consumables P/L S/F A/C> | 4,272,281 | 1.73% |
| Seguro Super Pty Ltd <Seguro Super Fund A/C> | 4,105,695 | 1.67% |
| Development Management & Constructions Pty Ltd | 3,916,353 | 1.59% |
| Citicorp Nominees Pty Limited | 3,451,820 | 1.40% |
| Lotsa Nominees Pty Ltd | 3,333,333 | 1.35% |
| Ken Zulumovski | 3,179,498 | 1.29% |
| Benlee Company Pty Ltd <The Benlee A/C> | 3,168,283 | 1.29% |
| BNP Paribas Noms Pty Ltd | 3,082,994 | 1.25% |
| OAM Investments Pty Ltd <OAM Investments P/L S/F A/C> | 2,923,346 | 1.19% |
